SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Krebs Biochemicals and Industries informs about newspaper advertisement

09 Sep 2022 Evaluate

Pursuant to Regulation 30 read with Schedule III Part A Para A of SEBI Listing Regulations, Krebs Biochemicals and Industries has informed that it enclosed copies of newspaper advertisement published in Business Standard (English) and Prajasakti (Telugu), regarding notice given to shareholders for intimating the date of Annual general meeting, cut-off date, e-voting etc. The above information is also available on the website of the Company www.krebsbiochem.com.

The above information is a part of company’s filings submitted to BSE.

Krebs Biochem.&Inds Share Price

60.90 -0.12 (-0.20%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×